James Watson weighs in against Myriad in gene patent debate

Watson Steve Jurvetson
James Watson (right) at an event in 2006. Credit: Steve Jurvetson

In recent years, most headlines regarding James D. Watson, the co-discoverer of DNA’s structure, have been related to his controversial remarks about gender, race, and sexuality. Just last week, at the Euroscience Open Forum in Dublin, he said of women in science, “I think having all these women around makes it more fun for the men but they’re probably less effective.”

But last month, he took a break from stirring the cultural pot to file an amicus brief in the ongoing dispute over whether a company can patent a gene.

His brief, filed last month, is technically “in support of neither party,” but he comes down decidedly against Myriad.

Read the full article here: DNA Structure Co-Discoverer James Watson Weighs In on Ongoing Gene Patent Case

Additional Resources:

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend